Tata Consumer readies nutrition products for India’s GLP-1 weight-loss drug users
Tata Consumer Products is developing protein, fibre, prebiotic and probiotic food and beverage offerings aimed at nutrition needs and side effects associated with growing use of weight-loss drugs such as Wegovy and Mounjaro.
Tata Consumer Products is developing food and beverage supplements, including protein, fibre, prebiotic and probiotic offerings, to address side effects and changing consumption patterns linked to rising use of weight-loss drugs in India.
Why this matters
The GLP-1 nutrition push extends Tata Consumer’s recent focus on protein-and-fibre foods, while digital channels reached 21% of sales and the company began a frozen-food rollout targeting mid-teens growth by FY27-end.
Retail-brand signals are accelerating, up 182900% QoQ.